(Q41494022)

English

Comparative Effectiveness Trial for Diabetic Macular Edema: Three Comparisons for the Price of 1 Study From the Diabetic Retinopathy Clinical Research Network

scientific article published on 18 June 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 October 2017

Comparative Effectiveness Trial for Diabetic Macular Edema: Three Comparisons for the Price of 1 Study From the Diabetic Retinopathy Clinical Research Network (English)

1 reference

Europe PubMed Central

1 October 2017

diabetic macular edema

1 reference

based on heuristic

inferred from title

Adam R Glassman

2

object named as

Adam R Glassman

1 reference

Europe PubMed Central

1 October 2017

1

object named as

Lee M Jampol

1 reference

Europe PubMed Central

1 October 2017

Neil M. Bressler

3

object named as

Neil M Bressler

1 reference

Europe PubMed Central

1 October 2017

language of work or name

0 references

publication date

18 June 2015

1 reference

Europe PubMed Central

1 October 2017

JAMA Ophthalmology

1 reference

Europe PubMed Central

1 October 2017

133

1 reference

Europe PubMed Central

1 October 2017

9

1 reference

Europe PubMed Central

1 October 2017

983-984

1 reference

Europe PubMed Central

1 October 2017

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567804

11 June 2018

Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567804

11 June 2018

Prevalence of and risk factors for diabetic macular edema in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567804

11 June 2018

Revolution to a new standard treatment of diabetic macular edema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567804

11 June 2018

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567804

11 June 2018

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567804

11 June 2018

Visual acuity as an outcome measure in clinical trials of retinal diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567804

19 August 2018

Identifiers

10.1001/JAMAOPHTHALMOL.2015.1880

1 reference

Europe PubMed Central

1 October 2017

1 reference

Europe PubMed Central

1 October 2017

1 reference

Europe PubMed Central

1 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41494022&oldid=2035019714"